These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 16787174)

  • 1. Nitric oxide synthase (NOS) as therapeutic target for asthma and chronic obstructive pulmonary disease.
    Ricciardolo FL; Nijkamp FP; Folkerts G
    Curr Drug Targets; 2006 Jun; 7(6):721-35. PubMed ID: 16787174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of nitric oxide pathways: therapeutic potential in asthma and chronic obstructive pulmonary disease.
    Redington AE
    Eur J Pharmacol; 2006 Mar; 533(1-3):263-76. PubMed ID: 16466650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide in health and disease of the respiratory system.
    Ricciardolo FL; Sterk PJ; Gaston B; Folkerts G
    Physiol Rev; 2004 Jul; 84(3):731-65. PubMed ID: 15269335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of aminoguanidine, an inhibitor of inducible nitric oxide synthase, on nitric oxide production and its metabolites in healthy control subjects, healthy smokers, and COPD patients.
    Brindicci C; Ito K; Torre O; Barnes PJ; Kharitonov SA
    Chest; 2009 Feb; 135(2):353-367. PubMed ID: 18719059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric oxide synthase inhibition: therapeutic potential in asthma.
    Mulrennan SA; Redington AE
    Treat Respir Med; 2004; 3(2):79-88. PubMed ID: 15182209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: possible therapeutic targets?
    Rochette L; Lorin J; Zeller M; Guilland JC; Lorgis L; Cottin Y; Vergely C
    Pharmacol Ther; 2013 Dec; 140(3):239-57. PubMed ID: 23859953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting arginase and nitric oxide metabolism in chronic airway diseases and their co-morbidities.
    van den Berg MP; Meurs H; Gosens R
    Curr Opin Pharmacol; 2018 Jun; 40():126-133. PubMed ID: 29729549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up regulation of nitric oxide synthase-nitric oxide system in the testis of rats undergoing autoimmune orchitis.
    Jarazo-Dietrich S; Jacobo P; Pérez CV; Guazzone VA; Lustig L; Theas MS
    Immunobiology; 2012 Aug; 217(8):778-87. PubMed ID: 22672990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Nitric oxide (NO) in the pathophysiology of asthma and interstitial lung diseases].
    Kasperska-Zajac A; Rogala B
    Postepy Hig Med Dosw; 2001; 55(4):525-40. PubMed ID: 11766229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of inducible nitric oxide synthase in respiratory diseases.
    Hesslinger C; Strub A; Boer R; Ulrich WR; Lehner MD; Braun C
    Biochem Soc Trans; 2009 Aug; 37(Pt 4):886-91. PubMed ID: 19614613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the nitric oxide-soluble guanylyl cyclase pathway in obstructive airway diseases.
    Dupont LL; Glynos C; Bracke KR; Brouckaert P; Brusselle GG
    Pulm Pharmacol Ther; 2014 Oct; 29(1):1-6. PubMed ID: 25043200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide in experimental joint inflammation. Benefit or detriment?
    Wahl SM; McCartney-Francis N; Chan J; Dionne R; Ta L; Orenstein JM
    Cells Tissues Organs; 2003; 174(1-2):26-33. PubMed ID: 12784039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacology of nitric oxide: molecular mechanisms and therapeutic strategies.
    Domenico R
    Curr Pharm Des; 2004; 10(14):1667-76. PubMed ID: 15134564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of different therapeutic strategies on exhaled NO and lung inflammation in asthma and COPD.
    Kharitonov SA
    Vascul Pharmacol; 2005 Dec; 43(6):371-8. PubMed ID: 16198155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cytotoxic effect of the NOS-mediated oxidative stress in MCF-7 cells after PbCl₂ exposure.
    Zhong L; Wang L; Xu L; Liu Q; Jiang L; Zhi Y; Lu W; Zhou P
    Environ Toxicol; 2016 May; 31(5):601-8. PubMed ID: 25410796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of nitric oxide in gastrointestinal inflammatory and ulcerative diseases: perspective for drugs development.
    Barrachina MD; Panés J; Esplugues JV
    Curr Pharm Des; 2001 Jan; 7(1):31-48. PubMed ID: 11172700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mediators of asthma: nitric oxide.
    Fischer A; Folkerts G; Geppetti P; Groneberg DA
    Pulm Pharmacol Ther; 2002; 15(2):73-81. PubMed ID: 12090780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative contributions of endothelial, inducible, and neuronal NOS to tone in the murine pulmonary circulation.
    Fagan KA; Tyler RC; Sato K; Fouty BW; Morris KG; Huang PL; McMurtry IF; Rodman DM
    Am J Physiol; 1999 Sep; 277(3):L472-8. PubMed ID: 10484454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide in the bovine oviduct: influence on contractile activity and nitric oxide synthase isoforms localization.
    Yilmaz O; Całka J; Bukowski R; Zalecki M; Wasowicz K; Jaroszewski JJ; Markiewicz W; Bulbul A; Ucar M
    Theriogenology; 2012 Apr; 77(7):1312-27. PubMed ID: 22225690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drugs targeting nitric oxide synthase for migraine treatment.
    Barbanti P; Egeo G; Aurilia C; Fofi L; Della-Morte D
    Expert Opin Investig Drugs; 2014 Aug; 23(8):1141-8. PubMed ID: 24818644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.